Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $13,589,323,339.00 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.5524
Revenue (TTM): $0.03 M
Dividend Yield: N/A%
ROE: -8.05%
Latest News
-
Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data
Sat, Feb 14, 2026 6:29 AM
-
Dolby Stock Down 18%, Yet This $8 Million Bet Signals Turnaround Potential
Fri, Feb 13, 2026 8:57 PM
-
Healthcare REIT Posts 16.4% NOI Growth as Shares Soar 93%: Why This Fund's New Stake Stands Out
Fri, Feb 13, 2026 8:41 PM
-
TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV) – Here’s Why
Tue, Feb 10, 2026 11:41 AM
-
Caterpillar To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Tue, Feb 10, 2026 9:07 AM
-
HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $33
Tue, Feb 10, 2026 7:47 AM
-
Deep Dive Into Roivant Sciences Stock: Analyst Perspectives (4 Ratings)
Mon, Feb 9, 2026 2:01 PM
-
Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $30
Mon, Feb 9, 2026 10:46 AM
-
Roivant Sciences (ROIV) Valuation Check After Strong Share Price Momentum
Mon, Feb 9, 2026 1:07 AM
-
Looking At The Narrative For Roivant Sciences ROIV After 2026 Catalyst And Litigation Shifts
Sun, Feb 8, 2026 3:06 PM
Key Financials
Financial data not available
